Medicines regulator to allow limited use of ivermectin for Covid-19 patients
Ivermectin is a cheap, off-patent, anti-parasitic drug not registered for human use in SA, but which has piqued the interest of researchers
27 January 2021 - 15:36
SA’s medicines regulator will allow doctors to prescribe ivermectin for coronavirus patients under a tightly controlled “compassionate use” programme, while it waits for stronger evidence to emerge from ongoing clinical trials, it announced on Wednesday.
Ivermectin is a cheap, off-patent, anti-parasitic drug that has not been registered for human use in SA. It has piqued the interest of researchers as a potential treatment for Covid-19, but regulators around the world have consistently said there is not yet enough data to confirm its safety and efficacy...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.